The integration of high throughput technologies for drug discovery

被引:6
作者
Sabbatini, GP [1 ]
Shirley, WA [1 ]
Coffen, DL [1 ]
机构
[1] Discovery Partners Int, San Diego, CA 92121 USA
关键词
D O I
10.1089/10870570152488400
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Producing quality clinical candidates less prone to late stage failure is greatly facilitated by better integration of the relevant high throughput functions and the inclusion of ADME/toxicology further upstream in the discovery process. We describe the tasks and their integration in the context of the design, make and test triad.
引用
收藏
页码:213 / 218
页数:6
相关论文
共 8 条
[1]   Fluorescence polarization assays for high throughput screening of G protein-coupled receptors [J].
Banks, P ;
Gosselin, M ;
Prystay, L .
JOURNAL OF BIOMOLECULAR SCREENING, 2000, 5 (03) :159-167
[2]  
CORTES R, 1996, COMBINATORIAL LIB SY
[3]  
Jung G., 1999, COMBINATORIAL CHEM S
[4]   A fluorescent cell-based assay for cytochrome P-450 isozyme 1A2 induction and inhibition [J].
Kelly, JH ;
Sussman, NL .
JOURNAL OF BIOMOLECULAR SCREENING, 2000, 5 (04) :249-253
[5]  
LEO AJ, 1995, CHEM PHARM BULL, V43, P976
[6]   Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings [J].
Lipinski, CA ;
Lombardo, F ;
Dominy, BW ;
Feeney, PJ .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) :3-25
[7]  
OUSTERHOUT JK, 1998, IEEE COMPUT MAGAZINE
[8]  
vanRossum G., 1991, CWI Quarterly, V4, P283